Clinical Trial Update: The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating whether high-dose vitamin D3 can reduce 28-day mortality in adults who are critically ill and vitamin D deficient, with context in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Vitamin Deficiency

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Medical University of Graz | Conditions: Critical Illness, Vitamin D Deficiency | Phase 3 | Status: RECRUITING